Marine S.
- Country
- France
- Department
- Oncologie digestive
Research Overview
- Phase 1 Study of OP-3136 in Patients with Advanced or Metastatic Solid Tumors
- Phase 3 Randomized Open-Label Study of OP-1250 Versus Standard of Care in ER+, HER2- Advanced or Metastatic Breast Cancer Post-Endocrine and CDK4/6 Inhibitor Therapy
- Evaluation of Circulating Tumor DNA-Guided Adjuvant Therapy with Fluorouracil, Folinic Acid, and Oxaliplatin in Stage II Colon Carcinoma
Data & Insights
Has run more than one trial at 39 of 216 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in the treatment of gastrointestinal cancers, with particular emphasis on colon carcinoma and pancreatic adenocarcinoma.
- Colon Cancer Management
- Pancreatic Cancer Treatment
- Advanced Stage Cancer Care
The investigator's work encompasses treatment strategies for both early-stage and metastatic disease states.
Precision Medicine
The investigator focuses on developing personalized treatment approaches using circulating tumor DNA analysis for treatment decision-making in cancer care.
- Biomarker-Based Treatment
- Molecular Diagnostics
- Treatment Selection Criteria
Their work integrates molecular diagnostics with therapeutic decision-making in gastrointestinal cancers.
Therapeutic Innovation
The investigator evaluates various therapeutic regimens including FOLFOX and gemcitabine based treatments for gastrointestinal cancers.
- Chemotherapy Optimization
- Treatment Efficacy Assessment
- Patient-Specific Protocols
Their research includes evaluation of treatment options for patients with varying fitness levels and disease stages.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.